Consistently, flow cytometry verified leukemia engraftment in the bone marrow and further demonstrated that sh-GAS6-AS1–treated mice exhibited lower percentages of hCD45+ cells in bone marrow than sh-Scb–treated mice (Fig. 7E-F). The gene discussed is GAS6; the disease is leukemia.